Lastas A， Graziene V， Barkauskas E， et al . Carotid artery atherosclerotic plaque: clinical and morphological-immunohistochemical correlation[J]. Med Sci Monit， 2004， 10（11）: 606-614.[2] Sekhon LH， Spence I， Morgan MK， et al . Chronic cerebral hypoperfusion in the rat: temporal delineation of effects and the in vitro ischemic threshold[J]. Brain Res， 1995， 704（1）: 107-111.[3] Touzé E. Natural history of asymptomatic carotid artery stenosis[J]. Rev Neurol， 2008， 164（10）: 793-800.[4] Redekop GJ. Extracranial carotid and vertebral artery dissection: a review[J]. Can J Neurol Sci， 2008， 35（2）: 146-152.[5] Daugherty A， Lu H， Howatt DA， et al . Modes of defining atherosclerosis in mouse models: relative merits and evolving standards[J]. Methods Mol Biol， 2009， 573: 1-15.[6] Shi ZS， Feng L， He X， et al . Vulnerable plaque in a Swine model of carotid atherosclerosis[J]. Am J Neuroradiol， 2009， 30（3）: 469-472.[7] Verbeuren TJ. Experimental models of thrombosis and atherosclerosis[J]. Therapie， 2006， 61（5）: 379-387.[8] Leshem SS， Lotsikas PJ， Reimer SB. In vitro expansion patterns of ameroid ring constrictors[J]. Am J Vet Res， 2008， 69（11）: 1520-1524.[9] Hartvigsen K， Binder CJ， Hansen LF， et al . A diet-induced hyperchole-sterolemic murine model to study atherogenesis without obesity and metabolic syndrome[J]. Arterioscler Thromb Vasc Biol， 2007， 27（4）: 878-885.[10] Ju '' zwiak S， Wójcicki J， Mokrzycki K， et al . Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits[J]. Pharmacol Rep， 2005， 57（5）: 604-609.[11] Siegel-Axel DI， Gawaz M. Platelets and endothelial cells[J]. Semin Thromb Hemost， 2007， 33（2）: 128-135.[12] Golledge J， Greenhalgh RM， Davies AH. The symptomatic carotid plaque[J]. Stroke， 2000， 31（3）: 774-781.[13] Horrow MM， DeMauro CA， Lee JS. Carotid ultrasonography: evaluation of carotid ultrasonography[J]. Rinsho Byori， 2007， 55（2）: 128-134.[14] Buschmann IR， Busch HJ， Mies G， et al .Therapeutic induction of arteriogenesis in hypoperfused rat brain via granulocyte-macrophage colony-stimulating factor[J]. Circulation， 2003， 108（5）:610-615.[15] Cieslicki K， Ciesla D. Investigations of flow and pressure distributions in physical model of the circle of Willis[J]. J Biomech， 2005， 38（11）: 2302-2310.[16] Horrow MM， DeMauro CA， Lee JS. Carotid Doppler: low velocity as a sign of significant disease[J]. Ultrasound Q， 2008， 24（3）: 155-160.[17] Krupiński J， Ka uza J， Kumar P， et al . Some remarks on the growth-rate and angiogenesis of microvessels in ischemic stroke[J]. Patol Pol， 1993， 44（4）: 203-209.[18] Krupinski J， Kaluza J， Kumar P， et al . Role of angiogenesis in patients with cerebral ischemic stroke[J]. Stroke， 1994， 25（9）: 1794-1798.[19] Kochanek J， Patrick M. Ischemic and traumatic brain injury: pathobiology and cellular mechanisms[J]. Crit Care Med， 1993， 21（9 Suppl）: S333-334.[20] Dirnagl U， Iadecola C， Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view[J]. Trends Neurosci， 1999， 22（9）: 391-397.[21] Fiskum G， Murphy AN， Beal MF. Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases[J]. J Cereb Blood Flow Metab， 1999， 19（4）: 351-369.[22] Johnson EM Jr， Greenlund LJ， Akins PT， et al . Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury[J]. J Neurotrauma， 1995， 12（5）: 843-852.[23] Mattson MP， Culmsee C， Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke[J]. Cell Tissue Res， 2000， 301（1）: 173-187.
